Skip to content

The effect of esketamine combined with ultrasound-guided peripheral nerve block of the hip joint capsule on early postoperative cognitive function in elderly diabetic patients undergoing total hip arthroplasty

The effect of esketamine combined with ultrasound-guided peripheral nerve block of the hip joint capsule on early postoperative cognitive function in elderly diabetic patients undergoing total hip arthroplasty

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116942
Enrollment
Unknown
Registered
2026-01-16
Start date
2026-02-12
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Opioid drugs combined with PENG block group(Group M):Opioid drugs combined with PENG block
Esketamine combined with PENG block group (Group E):Esketamine combined with PENG block

Sponsors

The Second Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age >= 65 years, any gender; 2. American Society of Anesthesiologists (ASA) classification: I–III; 3. Preoperative clinical indication for total hip arthroplasty (THA) treatment for the first time in patients undergoing total knee arthroplasty (TKA); 4. Type 2 diabetes with a disease course >= 1 year, without signs of diabetic peripheral neuropathy; 5. Cardiac function classification: I–III; 6. Patients who agree to receive postoperative analgesia; 7. Patients and their authorized representatives fully understand the content of this study and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients unsuitable for postoperative analgesia, such as those with infection at the puncture site or drug allergies; 2. Those with severe arrhythmias or liver and kidney dysfunction; 3. Patients who received local blockade treatment or long-term oral pain medication before surgery; 4. Those with a clear history of mental illness or alcohol and drug addiction; 5. Patients with severe central nervous system diseases who cannot undergo functional rehabilitation exercises; 6. Other individuals unsuitable for inclusion in the study, such as those with poor hearing, unclear expression, hemiplegia, long-term bedridden status, or limb disabilities.

Design outcomes

Primary

MeasureTime frame
MoCA score ;

Secondary

MeasureTime frame
GDS-15 score ;Serum S-100ß protein levels ;Activity NRS scores;Serum IL-6 levels ;Resting NRS scores;MoCA score one day before the operation and 48 hours after the operation;Serum Aß protein level;

Countries

China

Contacts

Public ContactZhang Peng

The Second Hospital of Shanxi Medical University

20505851@qq.com+86 351 336 0730

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026